Kusurinomadoguchi, Inc.
Stock Price Chart
2026/08/21 UpdatedPrice Trend
2026/08/21 UpdatedPrice & Trading Details
2026/08/21 UpdatedPRICE
TRADING
Shareholder Composition
Updated 2026/08/01Dividend History 1Years Growth
Updated 2026/08/23| Year | Dividend | Change |
|---|---|---|
| 2026 | ¥38 | +40.7% |
| 2025 | ¥27 | - |
Financial Performance
2026/08/23 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥7,421M | ¥8,721M | ¥11,199M | ¥12,330M |
| Gross Profit | ¥4,075M | ¥4,933M | ¥6,475M | ¥6,971M |
| Operating Income | ¥1,050M | ¥1,370M | ¥1,954M | ¥2,682M |
| Pretax Income | ¥847M | ¥1,315M | ¥1,661M | ¥2,636M |
| Net Income | ¥391M | ¥871M | ¥2,035M | ¥2,953M |
| EPS | ¥42.64 | ¥84.00 | ¥184.89 | ¥259.51 |
| Operating Margin | 14.15% | 15.71% | 17.45% | 21.75% |
| Balance Sheet | ||||
| Total Assets | ¥12,219M | ¥23,072M | ¥12,157M | ¥17,817M |
| Total Equity | ¥2,696M | ¥6,370M | ¥8,452M | ¥11,353M |
| Total Liabilities | ¥9,523M | ¥16,702M | ¥3,705M | ¥6,464M |
| Cash | ¥5,947M | ¥14,591M | ¥2,104M | ¥5,204M |
| Interest-bearing Debt | ¥125M | ¥5,412M | ¥64M | ¥2,821M |
| Equity Ratio | 22.06% | 27.61% | 69.52% | 63.72% |
| D/E Ratio | 0.05 | 0.85 | 0.01 | 0.25 |
| Cash Flow | ||||
| Operating CF | ¥3,097M | ¥2,627M | -¥5,327M | ¥2,947M |
| Investing CF | -¥1,537M | -¥1,795M | -¥1,801M | -¥2,295M |
| Financing CF | -¥635M | ¥7,812M | -¥5,359M | ¥2,225M |
| Free CF | ¥1,571M | ¥999M | -¥7,131M | ¥1,362M |
| Efficiency | ||||
| ROE | 14.52% | 13.67% | 24.08% | 26.01% |
| ROA | 3.20% | 3.77% | 16.74% | 16.57% |
Latest IR Information
-
Q1 FY2027 Financial Summary (Consolidated) [Japan GAAP]
Consolidated results for Q1 of the fiscal year ending March 2027 have been announced. YoY changes in net sales and each profit metric are disclosed. Segment information is provided in the appendix. The Financial Summary discloses the highlights of the...
Read more -
[Kusuri no Mado] 2027 Fiscal Year Q1 Consolidated Financial Results Overview
Consolidated results for the first quarter of the 2027 fiscal year were released. Net sales of 3,643 million yen, operating income of 784 million yen, ordinary income of 778 million yen, and net income attributable to owners of the parent...
Read more -
Notice on Share Buyback Status (July 2026)
Discloses the status of treasury stock acquisitions for July 2026. Shares acquired: 146,700 common shares; total amount: 34,572,400 yen; period: July 1–31, 2026; method of acquisition: market purchases under a discretionary trading contract.
Read more -
【Kusuri no Madoguchi】Subsidiary Acquisition of Human Resource Matching Platform for Pharmacies｜July 2026
Kusuri no Madoguchi has fully acquired a subsidiary that operates a personnel matching platform utilizing personality diagnosis and AI analysis technology, enhancing hiring and retention support for pharmacies.
Read more -
Notice on Share Buyback Status (June 2026)
Discloses June share buyback status. Shares acquired: 69,700; Total amount: 178,887,200 yen; Period: from June 8 to June 30, 2026 (execution basis); Method: market purchases (discretionary trading agreement)
Read more
Latest News (5 items)
Company Information
About
Kusurinomadoguchi, Inc. provides solutions for pharmacies and medical care in Japan. The company offers EPARK drug counter, a pharmacy/drugstore search and reservation site; matching site to buy and sell dead stock medicines at dispensing pharmacies; site for medicine counter telephone medical treatment; Care Daisy system to link recording systems and ICT devices; solution for purchasing pharmaceuticals; and system that allows for centralized management of outpatient reception, outpatient reservations, and online medical treatment. It also provides Pharmacy Support, a customer management system for repeat patients in the pharmacy industry; system specialized for dispensing pharmacies; matching service that connects nursing care facilities and pharmacies; solution from the purchase of pharmaceuticals to the purchase of immovable inventory; Online consultation by hospital support; online medication guidance; support solution to pharmacies; EPARK medicine notebook, a medication notebook that allows to make dispensing reservations and manage family medicines; and a system that allows patients to select the pharmacy they want to visit. The company was founded in 2004 and is headquartered in Tokyo, Japan.
